SANA
Sana Biotechnology Inc
NASDAQ: SANA · HEALTHCARE · BIOTECHNOLOGY
$3.29
+1.23% today
Updated 2026-04-30
Market cap
$877.47M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.96
Dividend yield
—
52W range
$2 – $7
Volume
3.1M
Sana Biotechnology Inc (SANA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-118.70%
ROA
-26.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-13.25M | — | — | — |
| 2019 | $0.00 | $-130.78M | — | — | — |
| 2020 | $0.00 | $-278.64M | — | — | — |
| 2021 | $0.00 | $-344.18M | — | — | — |
| 2022 | $0.00 | $-266.39M | — | — | — |
| 2023 | $0.00 | $-283.25M | — | — | — |
| 2024 | $0.00 | $-266.76M | — | — | — |
| 2025 | $0.00 | $-244.17M | — | — | — |